Mylan Inc. Subsidiary, Dey, L.P., Announces That Perforomist? Inhalation Solution Is Now Available For Maintenance Treatment Of COPD

Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), announced the launch of Perforomist? (formoterol fumarate) Inhalation Solution, which will be available nationwide through retail pharmacies, hospitals, long-term care facilities, and home healthcare companies. Perforomist? Inhalation Solution is indicated for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD). [click link for full article]

More: continued here

Filed under: Pharma Industry on October 9th, 2007